{
    "2020-05-19": [
        [
            {
                "time": "2023-11-07",
                "original_text": "Novartis Gets EC Approval for Gene Therapy Zolgensma in SMA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EC Approval",
                        "Gene Therapy",
                        "Zolgensma",
                        "SMA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-11-07",
                "original_text": "Trump's hydroxychloroquine use underscores line between drug's promise and 'happy talk'",
                "features": {
                    "keywords": [
                        "Trump",
                        "hydroxychloroquine",
                        "drug promise",
                        "happy talk"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "politics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-11-07",
                "original_text": "The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",
                "features": {
                    "keywords": [
                        "FDA Nod",
                        "Roche",
                        "Arbutus",
                        "HBV Therapy",
                        "Moderna",
                        "Stock Offering"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-07",
                "original_text": "Biotech Giant Amgen Is Nearing A Breakout, But Is AMGN Stock A Buy?",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Breakout",
                        "AMGN Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}